New Project on Medical Supply Chains Featured in German Media

Within this project, the team develops measures and strategies to ensure the availability of essential (life-saving) medicines in Germany. In the recent past, the German population has faced severe shortages of drugs – some of which are of an essential nature. The reasons for these shortages are diverse and cannot be fully attributed to the Covid pandemic. Many of the life-saving drugs that our population relies on is produced in China (and to a lesser extent) in India. The underlying supply chains are vulnarable and, at the same time, a potential target of geo-political considerations. The research team investigates and evaluates strategies to increase the availability of essential medicines and to decrease the dependence on individual countries in which suppliers of active pharmaceutical ingredients (API) are located. 

Because of recent shortages of medicines, and new legislation, proposed by Karl Lauterbach, the German Minister of Health, this important topic has received considerable attention in the public.

The work of our project and insights from Richard Pibernik have been featured in a number of recent media publications in Germany. Here is an excerpt:

https://www.goingpublic.de/life-sciences/9-livetalk-runde-forum-science-health-es-wird-knapp/

https://www.deutschlandfunk.de/hintergrund-100.html

https://www.br.de/nachrichten/bayern/medikamentenmangel-wege-zu-mehr-versorgungssicherheit,TTTt1eM